Cellosaurus logo
expasy logo

Cellosaurus TAW-925 (CVCL_Z044)

[Text version]
Cell line name TAW-925
Accession CVCL_Z044
Resource Identification Initiative To cite this cell line use: TAW-925 (RRID:CVCL_Z044)
Comments Group: Hybridoma fusion partner cell line.
Group: Patented cell line.
Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50095.
Population: Caucasian.
Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
Sequence variations
  • Mutation; HGNC; 11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
Disease Hereditary spherocytosis (NCIt: C97074)
Hereditary spherocytosis (ORDO: Orphanet_822)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_6544 (WIL2)
CVCL_B6D3 (AGC-78)CVCL_B6D2 (P7E9C7)
Sex of cell Male
Age at sampling 5Y
Category Transformed cell line

PubMed=3030301; DOI=10.1016/0006-291X(87)91485-9
Ichimori Y., Harada K., Hitotsumachi S., Tsukamoto K.
Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
Biochem. Biophys. Res. Commun. 142:805-812(1987)

Iwasa S., Ichimori Y., Kuriyama M.
A transformant cell line capable of producing a human monoclonal antibody, hybridoma, their production and use.
Patent number EP0305960A2, 08-Mar-1989

Iwasa S., Kuriyama M., Okazaki K., Toyoda Y.
Anti-human cancer protein complexes, their production and use.
Patent number EP0336405B1, 13-Jan-1993

Encyclopedic resources Wikidata; Q54971738
Entry history
Entry creation10-Apr-2015
Last entry update29-Jun-2023
Version number12